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1078–5Objectives. Endovascular repair of descending thoracic aortic lesions is associated with a substantial risk of perioperative
spinal cord ischaemia (SCI) which may lead to permanent paraplegia.
We performed a retrospective analysis of our experience in the endovascular treatment of descending thoracic aortic
lesions to define the incidence of SCI and to identify factors that contributed to its development.
Methods. 67 consecutive patients underwent stent graft repair for descending thoracic aortic lesions including degener-
ative aneurysm (n¼ 19), type B dissection (acute n¼ 2, chronic n¼ 15), traumatic rupture (acute n¼ 14, chronic n¼ 4),
penetrating aortic ulcer (n¼ 5), anastomotic false aneurysm (n¼ 4), mycotic aneurysm (n¼ 3) and embolic aortic lesion
(n¼ 1) between June 2000 and June 2005.
All procedures were performed with the patient under general anaesthesia and strict blood pressure monitoring. No
patient had intra-operative monitoring of spinal evoked potential or cerebrospinal fluid (CSF) drainage to prevent SCI.
Neurological evaluation was realized after recovery from general anaesthesia.
Fifteen factors, including nature of aortic disease, length of aortic coverage, number of stent-grafts, coverage of
the distal third of the thoracic aorta and subclavian artery coverage, were investigated as possible predictors of post-
operative SCI.
Results. Five patients (7.5%) had postoperative neurological deficits (immediate n¼ 2, delayed n¼ 3) referable to SCI.
Univariate analysis showed that length of aortic coverage (p< 0.001) and number of stent-grafts deployed (p¼ 0.02)
were significant predictors of SCI. Multivariate logistic regression analysis showed that length of aortic coverage was
the only independent significant predictor of SCI. ROC curve analysis revealed 205 mm of aortic length coverage as the
threshold for increased risk of postoperative SCI (p¼ 0.001), with specificity and sensitivity of 95.2 and 80% respectively.
Conclusion. In our study, length of aortic coverage is the only independent predictive factor of SCI after endovascular
treatment with 205 mm as a threshold for increased risk. Hence, methods to prevent SCI, especially those aimed at resto-
ration of an adequate spinal cord perfusion pressure, should be offered to patients requiring extensive coverage of the
descending thoracic aorta.
 2007 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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The use of stent-grafts has radically changed the treat-
ment of lesions of the descending thoracic aorta (DTA)
and endovascular repair now is considered an alter-
native to conventional surgery. Compared to conven-
tional surgery, endovascular treatment is associated
with a decrease in hospital mortality and post-
operative morbidity.1 However, spinal cord ischaemiasponding author. P. Piquet, Hoˆpital de la Timone, 254 rue
ierre, 13005 Marseille, France.
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884/000455+ 07 $34.00/0  2007 European Society for Vascula(SCI) remains a concern after the treatment of lesions
of the DTA by stent-grafts. Although the SCI rates re-
ported in the literature are generally lower than those
after conventional surgery,2 they can still be as high as
12%.3 Several risk factors have been suggested to ex-
plain the onset of SCI, including a past history of sur-
gery for aneurysm of the abdominal aorta (AAA),
peri-operative hypotension and the length of the aorta
covered.4
The goal of this study was to review our experience
in the endovascular treatment of DTA lesions to de-
fine the incidence of SCI and identify factors that con-
tributed to its development.r Surgery. Published by Elsevier Ltd. All rights reserved.
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Patients
From June 2000 to June 2005, 67 consecutive patients
were treated with stent-grafts for lesions of the arch
and the DTA. Among them 18 patients were consid-
ered high-surgical-risk candidates because of severe
co-morbidities including coronary artery disease
(myocardial infarction or angina with positive stress
test not amenable to revascularization), symptomatic
congestive heart failure (LVEF< 40%), aortic stenosis,
severe chronic obstructive pulmonary disease, ele-
vated creatinine >200 mmoles/l and/or age over 80.
During the study period, only two patients under-
went surgical treatment of a DTA aneurysm, one for
a tuberculous aneurysm and one for acute rupture
with a short distal neck.Pre-operative imaging
All the patients had high-resolution spiral CT-scans
prior to the endovascular procedure. Lengths were
calculated using centreline of flow algorithms,5
which allowed us to analyze the morphology of the
lesions to be treated, in terms of their length, maxi-
mum diameter and the distance that separated
them from the subclavian artery and the celiac trunk.
Selective intercostal artery angiography was not
performed.Diseases and therapeutic indications
In 22 patients, the aortic lesion treated was an aneu-
rysm (19 degenerative lesions and 3 mycotic lesions).
Seventeen patients had a type B aortic dissection: two
patients were treated at the acute phase for impend-
ing rupture and uncontrolled hypertension, fifteen
patients were treated in the chronic phase for aneu-
rysmal evolution and in this group only one patient
was treated as an emergency (painful dissecting aneu-
rysm). The goal of treatment was to seal the primary
entry tear, covering at least 10 cm distal to the tear.
Eighteen patients had a traumatic injury of the tho-
racic aorta (acute n¼ 14, chronic n¼ 4), 5 patients
had a penetrating ulcer, 4 patients had an anastomotic
false aneurysm and one patient had an embolic aortic
lesion. In 18 cases (26.9%), the procedure was per-
formed in an emergency setting for acute aortic rup-
ture and among these cases only 2 patients had
haemorrhagic shock.Eur J Vasc Endovasc Surg Vol 35, April 2008Covered stents
The stent-grafts implanted were: Talent (Medtronic,
Santa Rosa, CA), and TAG/Excluder (W.L. Gore &
Associates, Flagstaff, AZ).
Adapting the attachment zone
If the proximal attachment zone was short (<15 mm),
our policy was to cover the left subclavian artery
(LSA). Carotid-subclavian bypass or subclavian-carotid
transposition were performed in only two anatomical
settings: if the patient had only a left vertebral artery
or it was the dominant one (right hypoplastic vertebral
artery, diameter <50% of the left vertebral artery), and
to prevent a type II endoleak when the LSA arose from
an aneurysmal aortic segment. If it was necessary to
cover the left commoncarotid artery, an intercarotid by-
passwas performed. These interventionswere realized
prior to stent-graft placement. If the distal attachment
zone was short, we covered or embolized the celiac
trunk, provided angiographic evaluation showed ade-
quate collateral flow through the gastroduodenal and
pancreaticoduodenal arteries.6
Endovascular procedure
All the procedures were performed in the operating
room under general anesthesia with tracheal intuba-
tion, mechanical ventilation and strict monitoring of
the patient’s blood pressure: themean arterial pressure
(MAP) was maintained above 90 mmHg immediately
after stent-graft deployment and until the patients
awoke and had a neurological examination. An intra-
venous loading dose of heparin (50 U per kilogram of
body weight) was given at the beginning of the proce-
dure. None of the patients underwent monitoring of
spinal cord evoked potentials, nor drainage of their ce-
rebrospinal fluid (CSF) pre-operatively to prevent SCI.
Primary technical success was defined as successful de-
ployment of the stent-graft without conversion to
open surgery or mortality during the procedure and
without any resulting type I or III endoleak.7 For dis-
section, persistent false lumen flowwas not considered
an endoleak unless it arose from the primary entry tear.
If any unplanned endovascular or surgical procedures
were required to achieve the desired result, the term
primary assisted technical success was used.
Length of aortic coverage
The length of aortic coverage was measured either
during the procedure using a calibrated catheter or
457Incidence and Determinants of Spinal Cord Ischaemiaduring control CT-scan using centre-line measure-
ments, when the aorta was tortuous.
Surveillance
Paraplegia or paraparesis upon awakening after the
procedure was defined as immediate neurological impair-
ment. Neurological impairment preceded by a period
during which the patient’s neurological examination
was normal, was defined as delayed neurological
impairment. All the patients with neurological impair-
ment underwent intravenous anticoagulation target-
ing an ACT of 1.5 to avoid thrombus formation in the
spinal cord arterial system, immediate CSF drainage,
maintaining their CSF pressure below 10 mmHg for
48 to 72 hours and their MAP above 90 mmHg to in-
crease spinal cord perfusion.
Statistical analysis
The variables considered as potential risk factors for
SCI are listed in Table 1.
Statistical analysis was performed with SPSS for
Windows (version 11.5, 2002; SPSS Inc, Chicago, Illi-
nois, USA). Discontinuous variables were compared
using the Chi-two-square test or the Fisher probabili-
ties* test, according to appropriateness. Continuous
variables (expressed as median and range) were com-
pared using the Mann-Whitney non-parametric U
test. Logistic regressionwas used to assess the adjusted
likelihood of SCI. The tests were two-sided and con-
sidered as significant when p< 0.05. Bonferroni’sTable 1. Variables studied in the statistical analysis
Demographic data
Age
Gender
Past history
Tobacco use
Arterial hypertension
Coronary artery disease
Diabetes mellitus
Chronic obstructive pulmonary disease
Chronic renal failure
Previous surgery for AAA
Aortic disease
Type of lesion
Elective treatment vs aortic rupture
Procedure
Proximal or distal neck adaptation
LSA coverage
Coverage of the distal third of the DTA
Length of aorta covered
Number of stents used
AAA indicates abdominal aortic aneurysm, LSA indicates left sub-
clavian artery, DTA indicates descending thoracic aorta.correction method was used to correct for multiple
tests whenever necessary. Multifactorial analysis was
performed using an ascending stepwise method with
p¼ 0.10 as the input and output criterion for the
variables. The risk of SCI for the length of aorta covered
was assessed using the area under the receiver-
operating-characteristic curve (ROC). The threshold
values usedwere those which combined themaximum
values of sensitivity and specificity.Results
Patients
Over a 6-year period, 67 patients underwent endovas-
cular treatment of the thoracic aorta. There were 54
men (80.6%) and 13 women (19.4%). The mean age
was 66 years (range 19 to 93 years). Case details are
listed in Table 2.Deployment of the stent
Primary technical success was achieved in 57 patients
(85.1%). Conversion to open surgery was necessary
in 2 patients:
 One patient suffered an aortic rupture during the
procedure following balloon inflation for stent-
graft deployment and was treated with the addi-
tion of a stent-graft and a bypass to the visceral
trunk arteries covered by the stent-graft.
 Onepatientwith chronicdissectionhada right renal
artery thrombosis secondary to false-lumen throm-
bosis. He was treated with a right ilio-renal bypass.
At the end of the procedure, 5 patients had a type 1
proximal endoleak, one had a distal type 1 endoleak,
and 1 patient had a type III endoleak.
Assisted primary technical success was achieved in 59
patients (88%).
A post-procedure primary endoleak was noted on
first follow-up CT-scan in 8 patients (11.0%): 6 of theseTable 2. Medical conditions of the patient population
Medical conditions n %
Hypertension 36 53.7
Smoking 33 49.3
Coronary artery disease 14 20.9
COPD 13 19.4
Renal insufficiency 12 17.9
Previous aortic surgery 11 16.4
Diabetes mellitus 2 3
COPD indicates chronic obstructive pulmonary disease.
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Table 3. Length of aorta covered (mm)
Lesion Mean SD Median Minimum Maximum N
Aneurysm 191.8 64.1 172.5 115 350 22
Dissection 151.7 47.7 150.0 100 250 17
Traumatic rupture 117.8 25.2 115.0 75 200 18
Other 124.4 42.2 115.0 75 200 10
SD indicates standard deviation.
458 P. Amabile et al.were type 1 endoleak (5 proximal, 1 distal), 1 was type
II endoleak and 1 was type III endoleak.
Aortic coverage
The mean length of the thoracic aorta covered by
stent-grafts was 151.7 mm 56.8 mm (range 75 to
350 mm). The number of stents used was: 1 stent in
39 (58.2%) patients, 2 stents in 17 (25.4%) patients,
3 stents in 7 (10.4%) patients, 4 stents in 3 (4.5%)
patients, and 5 stents in the remainging (1.5%)
patient.
The length of stent-covered thoracic aorta was sig-
nificantly greater in patients who underwent stent-
graft placement for aneurysm ( p¼ 0.001). Details of
the length of the aorta covered according to the spe-
cific disease treated are provided in Table 3.
To ensure a correct stent-graft attachment and seal,
the ‘‘attachment zone’’ was adapted in 8 patients
(12%) for aortic lesions involving a part of the aortic
arch (n¼ 5) or the visceral segment of the aorta
(n¼ 3).
For the proximal attachment zone, a transposition
of the LSAwas performed in 3 patients, a combination
of an intercarotid and carotid-subclavian bypass inTable 4. In-hospital mortality: risk factors
Demographic datas, Comorbidities and Procedure details
Male sex
Age
Aneurysmal etiology
Aortic rupture
Smoking history
Hypertension
Diabetes mellitus
Coronary artery disease
Renal insufficiency
COPD
Previous AAA surgery
DCA
Proximal AZ surgical elongation
Distal AZ surgical elongation
SAC
Aortic coverage length
Number of stent-grafts
Paraplegia
Stroke
COPD indicates chronic obstructive pulmonary disease; DCA indicate
indicates attachment zone; SAC indicates left subclavian artery covera
Eur J Vasc Endovasc Surg Vol 35, April 20081 patient, and a combination of an intercarotid bypass
and a LSA transposition in 1 patient. The LSA was
partially covered without surgical revascularization
in 5 patients (7.5%); none of these patients developed
left upper limb ischaemia or SCI. For the distal attach-
ment zone, the celiac trunk was covered in 3 patients.
Prior embolization was performed in one of these pa-
tients. None of these patients developed bowel
ischaemia.Hospital mortality
Six patients (8.9%) died within 30 days of the stent-
graft procedure or during the hospital stay. The causes
of death were: myocardial infarction (n¼ 1), acute
mesenteric ischaemia (n¼ 1), aortic rupture (n¼ 1)
and multi-organ failure (n¼ 3). Five patients had elec-
tive management of their aortic disease and 1 patient
was treated as an emergency for a symptomatic my-
cotic aneurysm. Five of these 6 patients had contrain-
dication to open surgery.
The univariate analysis showed that the aneurysm
etiology ( p¼ 0.01), COPD ( p¼ 0.01), number of stents
deployed ( p¼ 0.03), were significant risk factors for
hospitalmortality.Details of the results of the univariate
analysis are given in Table 4. Among the patients who
died, twohadparaplegia. Theassociationbetweenpost-
operative SCI and increased inhospitalmortalitywas of
borderline significance ( p¼ 0.06).
In multivariate analysis only the etiology of the le-
sion treated (RR¼ 12.36, CI¼ 1.92e128.06, p¼ 0.03)
and history of COPD (RR¼ 11, CI¼ 1.48e81.45,
p¼ 0.02) were independent risk factors for hospital
mortality.Relative risk Confidence interval P value
1.22 0.12e62.68 1
1.05 0.99e1.11 0.11
12.94 1.26e625.49 0.01*
0 0e2.27 0.18
2.21 0.29e25.81 0.43
1.81 0.24e21.26 0.68
0 0e57.84 1
4.55 0.52e37.59 0.10
0.91 0.02e9.42 1
11.56 1.35e137.44 0.01*
1.02 0.02e10.68 1
e e 0.003*
0 0e12.80 1
3.87 0.06e58.46 0.32
0 0e5.95 0.59
1.01 0.99e1.02 0.19
2.18 1.04e4.54 0.03*
9.67 0.60e108.5 0.06*
12 0.13e956.57 0.17
s coverage of the distal third of the descending thoracic aorta; AZ
ge.
Table 5. Factors associated with spinal cord ischemia
Demographic datas, Comorbidities and Procedure details Relative risk Confidence interval P value
Age 1.04 0.98e1.11 0.18
Male sex 0.96 0.08e51.17 1
Etiology e e 0.35
Aortic rupture e e 0.31
Smoking history 0.67 0.05e6.28 1
Hypertension e e 0.06
Diabete mellitus e e 1
Coronary artery disease 6.95 0.68e88.85 0.06
Renal insufficiency e e 0.57
COPD 3.09 0.23e29.87 0.25
Previous AAA surgery 1.30 0.02e15.06 1
DCA 7.25 0.65e366.87 0.07
Proximal AZ surgical elongation 3.63 0.06e50.50 0.33
Distal AZ surgical elongation e e 1
SAC 1.69 0.03e20.07 0.52
Aortic coverage length 1.05 1.01e1.09 <0.001
Number of stent-grafts 2.70 1.20e6.09 0.02
COPD indicates chronic obstructive pulmonary disease; DCA indicates coverage of the distal third of the descending thoracic aorta; AZ
indicates attachement zone; SAC indicates left subclavian artery coverage.
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Five patients (7.5%) had neurological impairment at-
tributed to SCI. All the cases occurred after elective
treatment. Two presented with immediate and 3
with delayed impairment within 24 hours following
the procedure. Three patients had a complete paraple-
gia, none recovered and 2 died within 30 days after
the procedure. Two patients had mild paraparesis
and fully recovered once CSF drainage was initiated
and MAP maintained above 90 mmHg. Univariate
analysis showed that when a long portion of the aorta
was covered ( p< 0.001), or several stents were de-
ployed ( p¼ 0.02), the risk of postoperative SCI in-
creased significantly. Details of the results are givenFig. 1. ROC curve for the prediction of spinal cord ischemia.in Table 5. Multivariate analysis showed that only
the length of aorta covered was an independent risk
factor for postoperative SCI (RR¼ 1.05, CI¼ 1.01e
1.09, p< 0.001). The ROC curve for the risk of SCI as
a function of the length of aorta covered is shown in
Fig. 1, with the area under the curve equal to 0.96
(CI 95%, 0.90e1, p¼ 0.001). The critical length of aortic
coverage for SCI was 205 mm, with an 80% sensitivity
(CI 95%, 70.4e89.6) and specificity of 95.2% (CI 95%,
90e100.3). Fig. 2 shows the probability of SCI and
its relationship with the length of aorta covered.Discussion
SCI is a serious complication of the endovascular
treatment of lesions of the DTA with a reported fre-
quency that ranges from 0 to 12%.3,8 In our study,
the rate of SCI was 7.5% with permanent neurological
impairment noted in 4.5%, results that are comparableFig. 2. Probability of spinal cord ischemia and its relation-
ship with the length of aorta covered.
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460 P. Amabile et al.with data in the literature. These results also are com-
parable with those of surgical series in which the
usual rate of SCI ranges between 2.7% and 13.8%,2,9
Statistical analysis identified the length of aorta cov-
ered as the only independent predictive factor for
SCI after endovascular treatment in our series. Two
of the 5 patients who had SCI died within 30 days
of their procedure, which suggests that these adverse
outcomes may be closely related ( p¼ 0.06).
SCI after endovascular treatment occurs more
frequently when the arteries that supply the spinal
cord are sacrificed (Adamkiewicz’s artery, intercostal
and lumbar arteries), as well as after a period of hypo-
tension or as a result of emboli from aortic atheroma-
tous lesions.4 Our results clearly demonstrate that SCI
following endovascular treatment mainly is related to
the irreversible sacrifice of the intercostal arteries cov-
ered by the stent. Above a threshold of 205 mm, the
onset of SCI was predictable with a sensitivity and
specificity of 80% and 92.5%, respectively. Further,
univariate analysis identified the number of stent-
grafts deployed ( p¼ 0.02) as a predictive factor for
SCI. The length of aorta covered, as a predictive factor
of SCI, was first reported by Greenberg,3 compatible
with the spinal cord vascularization model proposed
by Griepp.10 In Griepp’s model, spinal cord vascular-
ization is dependent on many interchangeable collat-
eral arteries that supply the anterior spinal cord
artery, rather than a single dominant ‘‘Adamkiewicz
artery’’, which previously was considered essential
for maintaining spinal cord perfusion. Our results
are consistent with Griepp’s model because the num-
ber of intercostal arteries sacrificed increases with the
length of aorta covered. However, we have been un-
able to confirm that patients who have already had
AAA repair have a higher risk of SCI, since in the
group of 11 patients with history of AAA repair,
only one developed SCI.
Although it is an influential model, Griepp’s con-
cept does not apply to all clinical situations, especially
in terms of the area of aortic coverage. We divided the
DTA into thirds and hypothesised that coverage of the
distal third would be associated with a greater risk of
SCI. Although the association between coverage of the
distal third of the aorta and increased SCI was of bor-
derline significance only ( p¼ 0.07) our study had lim-
ited statistical power. Although there are no similar
published findings, we suggest that coverage of the
distal third of the DTA must be approached with cau-
tion, particularly if the patient has other risk factors
for development of SCI.
We also analyzed the impact of covering the LSA
during endovascular treatment, to determine whether
it played a role in generating spinal cord ischaemia:Eur J Vasc Endovasc Surg Vol 35, April 2008our results showed that it did not appear to be a con-
tributing factor. Since the anterior spinal artery arises
from the vertebral artery, an interruption of the flow
in the LSA could be associated with this type of com-
plication, especially if the left vertebral artery is dom-
inant. Complications related to occlusion of the LSA
are mainly ischaemia of the left upper limb or a stroke
in the vertebro-basilar territory.11 Our study was too
small to assess the role of subclavian vascularization
in the onset of SCI after placement of a stent-graft.
The only measure we applied systematically to pre-
vent spinal cord ischaemia consisted of maintaining
high MAP values throughout procedure until the
patients awoke. After occlusion of the intercostal ar-
teries, spinal cord perfusion pressure decreases: per-
fusion pressure is determined by calculating the
gradient between MAP and CSF pressure. Many pub-
lished articles demonstrate that a decrease in MAP
(below 60e70 mmHg) in the peri-operative period is
associated with the onset of SCI when thoracic or
thoraco-abdominal aneurysms are treated by either
conventional surgery12 or endovascular procedures,13
and in patients with delayed paraplegia, symptoms
regress when hypotension is corrected and combined
with CSF drainage.13 Therefore it is essential to make
sure that the patient’s haemodynamic status is moni-
tored closely both per- and post-operatively, to main-
tain MAP values above 90 mmHg.13,14
We did not perform either a pre-operative spinal
cord angiogram (SCA) because it is an invasive exam-
ination which is not exempt from embolic complica-
tions and only yields a precise roadmap of spinal
cord vascularization in 55 to 85.7% of patients.15,16
or peri-operative spinal cord monitoring, which is an-
other means of detecting SCI at an early stage during
the placement of thoracic stents.17
CSF drainage is not used as a routine practice in our
group, but it is important as a preventive measure. In
a randomized study,18 investigators demonstrated
that CSF drainage has the potential to prevent SCI after
surgery for thoracoabdominal aneurysm (TAA) and af-
ter surgery for aneurysm of the DTA when it is com-
bined with other prevention methods.9 Many cases of
SCI reversal following CSF drainage have been re-
ported after TAA surgery and after thoracic stenting.
In our series, for the patientswith delayed SCI (3 cases),
CSF drainage effected a clear improvement in a third of
the cases, a proportion consistent with figures in the lit-
erature. More recently, CSF drainage was proposed as
a preventive measure against SCI in high risk patients
treated by thoracic stent-grafts.4,13,19,20 Since there are
complications related to CSF drainage, especially the
risk of compressive haematoma of the spinal cord, we
feel that this technique should beused as aprophylactic
461Incidence and Determinants of Spinal Cord Ischaemiameasure only in patients in whom the aortic lesion re-
quires stent-graft coverage of a segment longer than
205 mm, and perhaps in those with a prior history of
AAA repair and/or poor pelvic vascularization with
limited collateral supply.
The main limitation of our study is that it is retro-
spective, although the data were collected prospec-
tively. The number of patients included is small and
the range of patients treated is broad, which limits
the statistical power of the study. Also, many of our
patients were treated for traumatic rupture (26.8%)
or dissection (25.3%), conditions for which we know
that the rate of spinal cord ischaemia is low after
placement of a stent-graft. However, despite the fact
that our study is descriptive, we have added to the ev-
idence that the length of aorta covered is of crucial im-
portance to the development of spinal cord ischaemia
after endovascular treatment.
Conclusions
The treatment of patients with lesions of the descend-
ing thoracic aorta by stent-grafts can cause SCI. In
terms of identifying patients who have an increased
risk of developing these neurological complications,
the length of aorta covered by the stent-graft was
the only independent predictive risk factor for spinal
cord ischaemia identified. In our non-controlled pro-
spective series, in patients for whom no systematic
preventive measure (CSF drainage, spinal cord
evoked potentials) was implemented, apart from strict
arterial pressure monitoring, a critical aortic treatment
length of 205 mm was a threshold beyond which there
exists an elevated risk of SCI. Thus, methods aimed at
maintaining spinal cord perfusion pressure (ie, CSF
drainage and maintenance of a high MAP) should
be proposed for patients whose lesion requires exten-
sive coverage of the descending thoracic aorta. Any
strategy aimed at the prevention of SCI must take
into account the multiple anatomical, physiological
and procedural factors related to this complication.References
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